Cargando…

Mutations in Hevin/Sparcl1 and risk of autism spectrum disorder

Detalles Bibliográficos
Autores principales:	Taketomi, Takumi, Tsuruta, Fuminori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075111/ https://www.ncbi.nlm.nih.gov/pubmed/36571352 http://dx.doi.org/10.4103/1673-5374.361543

Ejemplares similares

Autism-associated mutation in Hevin/Sparcl1 induces endoplasmic reticulum stress through structural instability
por: Taketomi, Takumi, et al.
Publicado: (2022)

Hevin/Sparcl1 drives pathological pain through spinal cord astrocyte and NMDA receptor signaling
por: Chen, Gang, et al.
Publicado: (2022)

The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder
por: Nuñez-delMoral, Amaia, et al.
Publicado: (2023)

Sparcl1 and Atherosclerosis
por: Cheng, Xu, et al.
Publicado: (2023)

New insights into the functions of PtdIns(3,5)P(2) in the pathogenisis of neurodegenerative disorders
por: Tsuruta, Fuminori
Publicado: (2016)

Towards an Understanding of Microglia and Border-Associated Macrophages
por: Taketomi, Takumi, et al.
Publicado: (2023)

Disadvantages of a SPARCling defense
por: Bashyam, Hema
Publicado: (2008)

Autism spectrum disorders: let’s talk about glucose?
por: Hoirisch-Clapauch, Silvia, et al.
Publicado: (2019)

Hevin Plays a Pivotal Role in Corneal Wound Healing
por: Chaurasia, Shyam S., et al.
Publicado: (2013)

Modulation of SPARC/Hevin Proteins in Alzheimer’s Disease Brain Injury
por: Strunz, Maximilian, et al.
Publicado: (2019)

Correction: Hevin Plays a Pivotal Role in Corneal Wound Healing
por: Chaurasia, Shyam S., et al.
Publicado: (2014)

Neuritogenic function of microglia in maternal immune activation and autism spectrum disorders
por: Kalavai, Srinidhi Venkatesan, et al.
Publicado: (2020)

Cohort-guided insights into gene–environment interactions in autism spectrum disorders
por: Lipkin, W. Ian, et al.
Publicado: (2023)

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Molecular and Cellular Insights: A Focus on Glycans and the HNK1 Epitope in Autism Spectrum Disorder
por: Hours, Camille M., et al.
Publicado: (2023)

Prognostic value of SPARCL1 in patients with colorectal cancer
por: Han, Wei, et al.
Publicado: (2018)

Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes
por: Xiao, Cheng, et al.
Publicado: (2021)

Microglial dynamics during brain development
por: Okajima, Tomomi, et al.
Publicado: (2018)

Exploring genes that control microglial heterogeneity and transition
por: Okajima, Tomomi, et al.
Publicado: (2021)

Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
por: Bose-Brill, Seuli, et al.
Publicado: (2017)

From Research to Practice: Toward the Examination of Combined Interventions for Autism Spectrum Disorders
por: London, Eric Bart, et al.
Publicado: (2021)

Sparcle: assigning transcripts to cells in multiplexed images
por: Prabhakaran, Sandhya
Publicado: (2022)

Associations of tumor suppressor SPARCL1 with cancer progression and prognosis
por: Li, Ting, et al.
Publicado: (2017)

The Interaction of Agricultural Pesticides and Marginal Iodine Nutrition Status as a Cause of Autism Spectrum Disorders
por: Sullivan, Kevin M.
Publicado: (2008)

Subgrouping the Autism “Spectrum": Reflections on DSM-5
por: Lai, Meng-Chuan, et al.
Publicado: (2013)

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation
por: Claeskens, A, et al.
Publicado: (2000)

Atorvastatin in stroke: a review of SPARCL and subgroup analysis
por: Huisa, Branko N, et al.
Publicado: (2010)

Invited Perspective: Air Pollution and Autism Spectrum Disorder: Are We There Yet?
por: Raz, Raanan, et al.
Publicado: (2022)

Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects
por: Muit, J. J., et al.
Publicado: (2019)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Altered Developmental Expression of the Astrocyte-Secreted Factors Hevin and SPARC in the Fragile X Mouse Model
por: Wallingford, Jessica, et al.
Publicado: (2017)

Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials
por: Narzisi, Antonio, et al.
Publicado: (2022)

Improving Treatment of Children with Autism Spectrum Disorder in Low- and Middle-Income Countries: The Role of Non-specialist Care Providers
por: Bello-Mojeed, Mashudat A., et al.
Publicado: (2013)

RELN Mutations in Autism Spectrum Disorder
por: Lammert, Dawn B., et al.
Publicado: (2016)

Cry, Baby, Cry: Expression of Distress As a Biomarker and Modulator in Autism Spectrum Disorder
por: Esposito, Gianluca, et al.
Publicado: (2017)

CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
por: Marchler-Bauer, Aron, et al.
Publicado: (2017)

SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
por: Zhang, Hai-Ping, et al.
Publicado: (2022)

Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues
por: Klingler, Anika, et al.
Publicado: (2020)

Mutation Analysis of the NRXN1 Gene in Autism Spectrum Disorders
por: Onay, H, et al.
Publicado: (2016)

Social circuits and their dysfunction in autism spectrum disorder
por: Sato, Masaaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_obt68hitv16bmi4juct1pld3jp